Circular Genomics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10935 Alexandria Way Ste 201, San Diego,...Phone Number
(505) 357-0792Website
www.circulargenomics.comRevenue
$5.3 MillionIndustry
About Circular Genomics
Circular Genomics is focused on advancing precision medicine through a novel circular RNA approach aimed at improving the diagnosis and treatment of psychiatric and neurological disorders. Their flagship product, MindLight, is the first antidepressant response test utilizing brain-derived biomarkers to predict patient responses to SSRI antidepressant treatment, thereby streamlining the treatment selection process. The company aims to enhance the treatment journey for individuals with mental health conditions by leveraging their expertise in circular RNA biomarkers. Circular Genomics is committed to fostering a better understanding of mental health and brain conditions to improve patient outcomes.Explore more
Circular Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Circular Genomics
Compare insights from companies similar to Circular Genomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Circular Genomics Tech Stack
A closer look at the technologies used by Circular Genomics
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Circular Genomics
Sign Up For FreeTo access detailed company insights
Circular Genomics is focused on advancing precision medicine through a novel circular RNA approach aimed at improving the diagnosis and treatment of psychiatric and neurological disorders. Their flagship product, MindLight, is the first antidepressant response test utilizing brain-derived biomarkers to predict patient responses to SSRI antidepressa... Read More
